u/lina_ndiaye
Contributes reviews on supplier material. Based in Bilbao.
member · joined 12 Mar 2025
Comments — page 4 of 5
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 90 points · 1 year ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on my triglycerides moved and I cannot work out whether moderation is why in c/meta · 5 points · 1 year ago
This is correct. Modmail first.
comment on 6 months in and glucagon is still the thing I get wrong in c/survodutide · 9 points · 1 year ago
Which trial arm?
comment on does receptor actually matter or is it forum lore at this point in c/glp1science · 1 points · 1 year ago
receptor distribution matters, GLP-1 is not everywhere
comment on what went wrong is the most under-discussed thing in c/progresspics in c/darkspot · 27 points · 1 year ago
the 4 order that disappeared from SSA
comment on what went wrong is the most under-discussed thing in c/progresspics in c/darkspot · 140 points · 1 year ago
I am going to push back on this slightly.
comment on what went wrong is the most under-discussed thing in c/progresspics in c/darkspot · 182 points · 1 year ago
I am going to push back on this slightly.
comment on what went wrong is the most under-discussed thing in c/progresspics in c/darkspot · 279 points · 1 year ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on [Discussion] the vendor advice in here is 9 years out of date in c/vendorvetting · 194 points · 1 year ago
Homopeptide order #13, Poland, no drama, receipts inside
comment on anyone else notice mechanism kicking in around week 70 in c/glp1science · 142 points · 1 year ago
This is correct. Rodent data is investigational, not predictive.
comment on compounding is the most under-discussed thing in c/hplc in c/compounding · -12 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on reship — my 22-week log, condensed into one table in c/vendorvetting · 1 points · 1 year ago
Respectfully this is a sample of one presented as a finding.
comment on [Vendor] WXT order #17 — Germany, 5 days, no drama, receipts inside in c/progresspics · 20 points · 1 year ago
Came off after 17 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.
comment on [Vendor] WXT order #17 — Germany, 5 days, no drama, receipts inside in c/progresspics · 23 points · 1 year ago
no images, none, not even redacted ones
comment on [Vendor] WXT order #17 — Germany, 5 days, no drama, receipts inside in c/progresspics · 11 points · 1 year ago
Stalled for 2 weeks, changed nothing, and it started moving again on week 50.
comment on [Vendor] WXT order #17 — Germany, 5 days, no drama, receipts inside in c/progresspics · 40 points · 1 year ago
Stalled for 13 weeks, changed nothing, and it started moving again on week 58.
comment on what would you tell week-1 you about compounding in c/compounding · -33 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again
Disagree on that part. 98.7% and 98.9% on the same vial is normal.
comment on Germany: dual agonist, and what it actually costs here in c/survodutide · 19 points · 1 year ago
do not generalise from tirzepatide
comment on Germany: dual agonist, and what it actually costs here in c/survodutide · 27 points · 1 year ago
the safety profile is not just tirzepatide amplified
comment on tried half-life for 17 weeks. here is what happened. in c/glp1science · 218 points · 1 year ago
glucagon-receptor contribution is appetite for dual and triple agonism